Nephrogenic fibrosing dermopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Nephrogenic fibrosing dermopathy}}
{{Nephrogenic fibrosing dermopathy}}


{{CMG}}'''Assistant Editor-in-Chief:''' [[Brian Blank]]
{{CMG}}''' Assistant Editor-in-Chief:''' [[Brian Blank]]


{{SK}} nephrogenic systemic fibrosis
{{SK}} nephrogenic systemic fibrosis


==[[Osteoporosis overview|Overview]]==
==[[Nephrogenic fibrosing dermopathy overview|Overview]]==


==[[Osteoporosis historical perspective|Historical Perspective]]==
==[[Nephrogenic fibrosing dermopathy historical perspective|Historical Perspective]]==


==[[Osteoporosis classification scheme|Classification]]==
==[[Nephrogenic fibrosing dermopathy classification scheme|Classification]]==


==[[Osteoporosis pathophysiology|Pathophysiology]]==
==[[Nephrogenic fibrosing dermopathy pathophysiology|Pathophysiology]]==


==[[Osteoporosis causes|Causes]]==
==[[Nephrogenic fibrosing dermopathy causes|Causes]]==


==[[Osteoporosis differential diagnosis|Differentiating Osteoporosis from other Diseases]]==
==[[Nephrogenic fibrosing dermopathy differential diagnosis|Differentiating Nephrogenic fibrosing dermopathy from other Diseases]]==


==[[Osteoporosis epidemiology and demographics|Epidemiology and Demographics]]==
==[[Nephrogenic fibrosing dermopathy epidemiology and demographics|Epidemiology and Demographics]]==


==[[Osteoporosis risk factors|Risk Factors]]==
==[[Nephrogenic fibrosing dermopathy risk factors|Risk Factors]]==


==[[Osteoporosis screening|Screening]]==
==[[Nephrogenic fibrosing dermopathy screening|Screening]]==


==[[Osteoporosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Nephrogenic fibrosing dermopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==


[[Osteoporosis history and symptoms|History and Symptoms ]] | [[ Osteoporosis physical examination|Physical Examination]] | [[Osteoporosis laboratory findings|Laboratory Findings]] | [[Osteoporosis x ray|X-Ray]] | [[Osteoporosis CT|CT]] | [[Osteoporosis MRI|MRI]] | [[Osteoporosis echocardiogram or ultrasound|Echocardiogram or Ultrasound]] | [[Osteoporosis other imaging findings|Other Imaging Findings]] | [[Osteoporosis other diagnostic studies|Other Diagnostic Studies]]
[[Nephrogenic fibrosing dermopathy history and symptoms|History and Symptoms ]] | [[ Nephrogenic fibrosing dermopathy physical examination|Physical Examination]] | [[Nephrogenic fibrosing dermopathy laboratory findings|Laboratory Findings]] | [[Nephrogenic fibrosing dermopathy x ray|X-Ray]] | [[Nephrogenic fibrosing dermopathy CT|CT]] | [[Nephrogenic fibrosing dermopathy MRI|MRI]] | [[Nephrogenic fibrosing dermopathy echocardiogram or ultrasound|Echocardiogram or Ultrasound]] | [[Nephrogenic fibrosing dermopathy other imaging findings|Other Imaging Findings]] | [[Nephrogenic fibrosing dermopathy other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Osteoporosis medical therapy|Medical Therapy]] | [[Osteoporosis surgery |Surgery]] | [[Osteoporosis primary prevention|Primary Prevention]] | [[Osteoporosis secondary prevention|Secondary Prevention]] | [[Osteoporosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Osteoporosis future or investigational therapies|Future or Investigational Therapies]]
[[Nephrogenic fibrosing dermopathy medical therapy|Medical Therapy]] | [[Nephrogenic fibrosing dermopathy surgery |Surgery]] | [[Nephrogenic fibrosing dermopathy primary prevention|Primary Prevention]] | [[Nephrogenic fibrosing dermopathy secondary prevention|Secondary Prevention]] | [[Nephrogenic fibrosing dermopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nephrogenic fibrosing dermopathy future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
[[Osteoporosis case study one|Case #1]]
[[Nephrogenic fibrosing dermopathy case study one|Case #1]]


==Source==
==Source==

Revision as of 15:05, 28 September 2012

Nephrogenic fibrosing dermopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nephrogenic fibrosing dermopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nephrogenic fibrosing dermopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nephrogenic fibrosing dermopathy

CDC on Nephrogenic fibrosing dermopathy

Nephrogenic fibrosing dermopathy in the news

Blogs on Nephrogenic fibrosing dermopathy

Directions to Hospitals Treating Nephrogenic fibrosing dermopathy

Risk calculators and risk factors for Nephrogenic fibrosing dermopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editor-in-Chief: Brian Blank

Synonyms and keywords: nephrogenic systemic fibrosis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nephrogenic fibrosing dermopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X-Ray | CT | MRI | Echocardiogram or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Source



de:Nephrogene systemische Fibrose Template:WH Template:WS